Abstract
The P450 family of proteins has more than 1000 representatives,which despite sometimes relatively low sequence identity have a surprisingly high level of structural similarity.This fact makes this family of proteins ideal candidate for various types of modeling based on protein structure prediction.A number of P450 proteins,including CYPs 1A1,1A2,1B1,3A4,11B2,17,and 19,play a role in the metabolism of estrogen.Inhibitors of these proteins could be very promising drugs for hormonal treatment of postmenopausal breast cancer.Population studies have yielded a significant amount of data describing the relationship between single nucleotide polymorphisms (SNP)in DNA and cancer risk related to these proteins. A combination of SNP analysis with protein structure prediction can be a very useful strategy in investigations of structure-functional relations of P450 proteins and structure-based drug design.Here we will demonstrate how protein structure prediction combined with genetic SNP analysis can be useful for potential drug design and possibly,individual treatment of breast cancer.
Keywords: P450, breast cancer, proteins, postmenopausal
Current Medicinal Chemistry
Title: SNP Analysis Combined with Protein Structure Prediction Defines Structure- Functional Relationships in Cancer Related Cytochrome P450 Estrogen Metabolism
Volume: 11 Issue: 5
Author(s): Igor F. Tsigelny, Vladimir Kotlovyi and Linda Wasserman
Affiliation:
Keywords: P450, breast cancer, proteins, postmenopausal
Abstract: The P450 family of proteins has more than 1000 representatives,which despite sometimes relatively low sequence identity have a surprisingly high level of structural similarity.This fact makes this family of proteins ideal candidate for various types of modeling based on protein structure prediction.A number of P450 proteins,including CYPs 1A1,1A2,1B1,3A4,11B2,17,and 19,play a role in the metabolism of estrogen.Inhibitors of these proteins could be very promising drugs for hormonal treatment of postmenopausal breast cancer.Population studies have yielded a significant amount of data describing the relationship between single nucleotide polymorphisms (SNP)in DNA and cancer risk related to these proteins. A combination of SNP analysis with protein structure prediction can be a very useful strategy in investigations of structure-functional relations of P450 proteins and structure-based drug design.Here we will demonstrate how protein structure prediction combined with genetic SNP analysis can be useful for potential drug design and possibly,individual treatment of breast cancer.
Export Options
About this article
Cite this article as:
Tsigelny F. Igor, Kotlovyi Vladimir and Wasserman Linda, SNP Analysis Combined with Protein Structure Prediction Defines Structure- Functional Relationships in Cancer Related Cytochrome P450 Estrogen Metabolism, Current Medicinal Chemistry 2004; 11 (5) . https://dx.doi.org/10.2174/0929867043455882
DOI https://dx.doi.org/10.2174/0929867043455882 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Role of Gut Microbiota in Human Health and Diseases
Current Nutrition & Food Science Editorial [Hot Topic: How Drugs may Work to Better Protect the Gastrointestinal Tract: Mechanisms Involved in Gastrointestinal Tract Protection]
Current Pharmaceutical Design Membrane Disrupting Lytic Peptides for Cancer Treatments
Current Pharmaceutical Design KRAS Mutation Testing of Colorectal Cancer for Anti-EGFR Therapy: Dogmas Versus Evidence
Current Cancer Drug Targets Positron Emission Tomography: Applications In Drug Discovery and Drug Development
Current Topics in Medicinal Chemistry Editorial (Moving Beyond Our Mutual Ignorance. Or, How would Engaging the Public Benefit the Personalized Medicine Community?)
Current Pharmacogenomics and Personalized Medicine Toll-Like Receptor Signaling: Emerging Opportunities in Human Diseases and Medicine
Current Immunology Reviews (Discontinued) Interaction of Macrocyclic Lactones with the Multidrug Transporters: The Bases of the Pharmacokinetics of Lipid-Like Drugs
Current Drug Metabolism Patent Selections
Recent Patents on Anti-Cancer Drug Discovery Histone Deacetylase Inhibitors: A Review on Class-I Specific Inhibition
Mini-Reviews in Medicinal Chemistry Physiology of Immune System: Regulation of Stem Cell Survival
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Recent Developments in Chimeric NSAIDs as Anticancer Agents: Teaching an Old Dog a New Trick
Mini-Reviews in Medicinal Chemistry Surgical Clips in Breast-conserving Surgery: Do they Represent the Tumour Bed Accurately?
Current Medical Imaging Recent Advances in the Characterization of Genetic Factors Involved in Human Susceptibility to Infection by Schistosomiasis
Current Genomics Anti-HER2 Treatment and Breast Cancer: State of the Art, Recent Patents, and New Strategies
Recent Patents on Anti-Cancer Drug Discovery Exploring PLAC1 Structure and Underlying Mechanisms to Design a Derivative Vaccine Against Breast Cancer Progression; <i>In-Silico</i> Study
Current Proteomics Reversal of ABC Drug Transporter-Mediated Multidrug Resistance in Cancer Cells: Evaluation of Current Strategies
Current Molecular Pharmacology Sensitive and Selective Immunofluorescence Assay for CA15-3 Detection Using Fluorescein Derivative A10254
Protein & Peptide Letters Targeting AMPK Signaling Pathway to Overcome Drug Resistance for Cancer Therapy
Current Drug Targets Recent Trends of Biocompatible and Biodegradable Nanoparticles in Drug Delivery: A Review
Current Medicinal Chemistry